EP3189078 - ANTI-CK8 ANTIBODIES FOR USE IN THE TREATMENT OF CANCERS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.09.2021 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 02.10.2020 | ||
Former | Grant of patent is intended Status updated on 19.05.2020 | ||
Former | Examination is in progress Status updated on 22.06.2018 | ||
Former | Request for examination was made Status updated on 09.06.2017 | ||
Former | The international publication has been made Status updated on 24.02.2017 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states International-Drug-Development-Biotech 317 Avenue Jean Jaurès Bâtiment Accinov 69007 Lyon / FR | For all designated states Université Claude Bernard Lyon 1 43 Boulevard du 11 Novembre 1918 69100 Villeurbanne / FR | For all designated states Hospices Civils De Lyon 3, Quai des Célestins 69002 Lyon / FR | For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3, rue Michel-Ange 75016 Paris / FR | For all designated states Institut National de la Santé et de la Recherche Médicale (INSERM) 101, rue de Tolbiac 75013 Paris / FR | For all designated states Centre Léon-Bérard 28 rue Laënnec 69008 Lyon / FR | [2020/50] |
Former [2020/45] | For all designated states International-Drug-Development-Biotech 317 Avenue Jean Jaurès Bâtiment Accinov 69007 Lyon / FR | ||
For all designated states Université Claude Bernard Lyon 1 43 Boulevard du 11 Novembre 1918 69100 Villeurbanne / FR | |||
For all designated states Hospices Civils De Lyon 3, Quai des Célestins 69002 Lyon / FR | |||
For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3, rue Michel-Ange 75016 Paris / FR | |||
For all designated states Institut National de la Santé et de la Recherche Médicale (INSERM) 101, rue de Tolbiac 75013 Paris / FR | |||
For all designated states Centre de Lutte Contre le Cancer Léon Bérard 28 Rue Laennec 69008 Lyon / FR | |||
Former [2017/28] | For all designated states International-Drug-Development-Biotech 317 Avenue Jean Jaurès Bâtiment Accinov 69007 Lyon / FR | ||
For all designated states Université Claude Bernard Lyon 1 43 Boulevard du 11 Novembre 1918 69100 Villeurbanne / FR | |||
For all designated states Hospices Civils De Lyon 3, Quai des Célestins 69002 Lyon / FR | |||
For all designated states Centre National de la Recherche Scientifique (C.N.R.S.) 3, rue Michel-Ange 75016 Paris / FR | |||
For all designated states Institut National de la Santé et de la Recherche Médicale (INSERM) 101, rue de Tolbiac 75013 Paris / FR | |||
For all designated states Centre de Lutte Contre le Cancer Léon Bérard 28 Rue Laennec 69008 Lyon / FR | Inventor(s) | 01 /
ALBARET, Marie, Alexandra 24 avenue du Galoubier F-38080 l'Isle d'Abeau / FR | 02 /
DIAZ, Jean-Jacques 8 rue du Colonel F-69200 Venissieux / FR | 03 /
MERTANI, Hichem, Claude 185 rue Bataille F-69008 Lyon / FR | 04 /
SAURIN, Jean-Christophe 27 rue Ferdinand Buisson F-69003 Lyon / FR | 05 /
VERMOT-DESROCHES, Claudine Allée des Terrasses Bat G. F-69570 Dardilly / FR | 06 /
VUILLERMOZ, Boris 79 route Nationale 6 F-69380 Les Chères / FR | [2017/28] | Representative(s) | Lavoix 62, rue de Bonnel 69448 Lyon Cedex 03 / FR | [2017/28] | Application number, filing date | 15748040.1 | 10.08.2015 | [2017/28] | WO2015EP68400 | Priority number, date | FR20140057704 | 08.08.2014 Original published format: FR 1457704 | [2017/28] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016020553 | Date: | 11.02.2016 | Language: | EN | [2016/06] | Type: | A1 Application with search report | No.: | EP3189078 | Date: | 12.07.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.02.2016 takes the place of the publication of the European patent application. | [2017/28] | Type: | B1 Patent specification | No.: | EP3189078 | Date: | 04.11.2020 | Language: | EN | [2020/45] | Search report(s) | International search report - published on: | EP | 11.02.2016 | Classification | IPC: | A61P35/00, C07K16/18, C07K16/30, A61K39/00 | [2020/20] | CPC: |
C07K16/18 (EP,CN,IL,KR,US);
A61K39/39558 (US);
A61K45/06 (US);
A61P35/00 (EP,US);
C07K14/4741 (CN);
C07K16/3015 (EP,CN,IL,KR,US);
C07K16/3046 (EP,CN,IL,KR,US);
C07K16/3061 (US);
C07K7/06 (US);
G01N33/57419 (US);
A61K2039/505 (EP,CN,IL,KR,US);
A61K2039/545 (US);
A61K39/00 (EP,CN,IL,KR,US);
C07K2317/24 (EP,CN,IL,KR,US);
C07K2317/34 (EP,CN,IL,KR,US);
C07K2317/565 (US);
C07K2317/73 (EP,CN,IL,KR,US);
C07K2317/76 (EP,CN,IL,KR,US);
G01N2410/00 (US)
(-)
|
Former IPC [2017/28] | C07K16/18, C07K16/30, A61K39/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/28] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | ANTI-CK8 ANTIKÖRPER ZUR VERWENDUNG BEI DER BEHANDLUNG VON KREBS | [2020/20] | English: | ANTI-CK8 ANTIBODIES FOR USE IN THE TREATMENT OF CANCERS | [2017/28] | French: | ANTICOPRS ANTI CK-8 ET LEURS UTILISATIONS DANS LE TRAITEMENT DE CANCERS | [2020/20] |
Former [2017/28] | ANTI-CK8-ANTIKÖRPER ZUR VERWENDUNG IN DER KREBSBEHANDLUNG | ||
Former [2017/28] | ANTICORPS ANTI-CK8 DESTINÉS À ÊTRE UTILISÉS DANS LE TRAITEMENT DE CANCERS | Entry into regional phase | 23.02.2017 | National basic fee paid | 23.02.2017 | Designation fee(s) paid | 23.02.2017 | Examination fee paid | Examination procedure | 23.02.2017 | Examination requested [2017/28] | 23.02.2017 | Date on which the examining division has become responsible | 20.09.2017 | Amendment by applicant (claims and/or description) | 26.09.2017 | Loss of particular rights, legal effect: Claims | 06.11.2017 | Despatch of communication of loss of particular rights: Claims {1} | 20.06.2018 | Despatch of a communication from the examining division (Time limit: M06) | 21.12.2018 | Reply to a communication from the examining division | 10.05.2019 | Despatch of a communication from the examining division (Time limit: M04) | 16.08.2019 | Reply to a communication from the examining division | 20.05.2020 | Communication of intention to grant the patent | 21.09.2020 | Fee for grant paid | 21.09.2020 | Fee for publishing/printing paid | 21.09.2020 | Receipt of the translation of the claim(s) | 20.10.2020 | Request for correction of the decision to grant filed | Opposition(s) | 05.08.2021 | No opposition filed within time limit [2021/41] | Fees paid | Renewal fee | 28.08.2017 | Renewal fee patent year 03 | 25.10.2018 | Renewal fee patent year 04 | 22.07.2019 | Renewal fee patent year 05 | 16.07.2020 | Renewal fee patent year 06 | Penalty fee | Additional fee for renewal fee | 31.08.2018 | 04   M06   Fee paid on   25.10.2018 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 10.08.2015 | AL | 04.11.2020 | AT | 04.11.2020 | CY | 04.11.2020 | CZ | 04.11.2020 | DK | 04.11.2020 | EE | 04.11.2020 | ES | 04.11.2020 | FI | 04.11.2020 | HR | 04.11.2020 | IT | 04.11.2020 | LT | 04.11.2020 | LV | 04.11.2020 | MC | 04.11.2020 | MK | 04.11.2020 | PL | 04.11.2020 | RO | 04.11.2020 | RS | 04.11.2020 | SE | 04.11.2020 | SI | 04.11.2020 | SK | 04.11.2020 | SM | 04.11.2020 | TR | 04.11.2020 | BG | 04.02.2021 | NO | 04.02.2021 | GR | 05.02.2021 | IS | 04.03.2021 | PT | 04.03.2021 | [2024/29] |
Former [2024/22] | HU | 10.08.2015 | |
AL | 04.11.2020 | ||
AT | 04.11.2020 | ||
CY | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
MC | 04.11.2020 | ||
MK | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2023/30] | HU | 10.08.2015 | |
AL | 04.11.2020 | ||
AT | 04.11.2020 | ||
CY | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
MC | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2023/29] | HU | 10.08.2015 | |
AL | 04.11.2020 | ||
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
MC | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2022/23] | AL | 04.11.2020 | |
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
MC | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2022/18] | AL | 04.11.2020 | |
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
MC | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
PT | 04.03.2021 | ||
Former [2022/10] | AL | 04.11.2020 | |
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
PT | 04.03.2021 | ||
Former [2021/50] | AL | 04.11.2020 | |
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SI | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/48] | AL | 04.11.2020 | |
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
IT | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/45] | AL | 04.11.2020 | |
AT | 04.11.2020 | ||
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/37] | AT | 04.11.2020 | |
CZ | 04.11.2020 | ||
DK | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/36] | AT | 04.11.2020 | |
CZ | 04.11.2020 | ||
EE | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/35] | AT | 04.11.2020 | |
CZ | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RO | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SK | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/34] | AT | 04.11.2020 | |
CZ | 04.11.2020 | ||
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/33] | AT | 04.11.2020 | |
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LT | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/32] | AT | 04.11.2020 | |
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
SM | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/28] | AT | 04.11.2020 | |
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
HR | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/25] | AT | 04.11.2020 | |
ES | 04.11.2020 | ||
FI | 04.11.2020 | ||
LV | 04.11.2020 | ||
PL | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
IS | 04.03.2021 | ||
PT | 04.03.2021 | ||
Former [2021/23] | AT | 04.11.2020 | |
FI | 04.11.2020 | ||
LV | 04.11.2020 | ||
RS | 04.11.2020 | ||
SE | 04.11.2020 | ||
BG | 04.02.2021 | ||
NO | 04.02.2021 | ||
GR | 05.02.2021 | ||
PT | 04.03.2021 | ||
Former [2021/22] | FI | 04.11.2020 | |
RS | 04.11.2020 | ||
NO | 04.02.2021 | ||
PT | 04.03.2021 | ||
Former [2021/21] | FI | 04.11.2020 | |
PT | 04.03.2021 | ||
Former [2021/20] | FI | 04.11.2020 | Cited in | International search | [XI]WO2010136536 (UNIV CLAUDE BERNARD LYON [FR], et al) |